Qube Research & Technologies LTD Jounce Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$5.04 - $8.73 $388,553 - $673,030	-77,094 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.58 - $10.66 $387,410 - $627,628	58,877 Added 323.2%	77,094 $524,000
Q1 2021 May 14, 2021	BUY	$6.73 - $13.87 $122,600 - $252,669	18,217 New	18,217 $187,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.